The University of Chicago Header Logo

Connection

Mark Kozloff to In Situ Hybridization, Fluorescence

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about In Situ Hybridization, Fluorescence.
Mark Kozloff
Connection Strength
0.019
In Situ Hybridization, Fluorescence
  1. Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer. J Thorac Oncol. 2008 Sep; 3(9):1003-11.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.